Paragon

Burn

2026

Nano

<img width="1600" height="900" src="https://financefeeds.com/wp-content/uploads/2026/07/smr-stock-25-bull-case-7-bear-case-jpg.webp" alt="NuScale SMR Stock: $25 Bull Case, $7 Bear Case" title="NuScale SMR Stock: $25 Bull Case, $7 Bear Case 80">
The consensus reading of NuScale Power's 85% collapse — from a $57.42 high to $8.36 — is that the small modular reactor trade is dead. The numbers say something stranger: strip out NuScale's $1.2 billion in liquidity and the market is valuing the only reactor design ever approved by the US Nuclear Regulatory Commission (NRC), plus a pipeline of up to 6 gigawatts with the Tennessee Valley Authority (TVA), at roughly $1.9 billion of enterprise value — a fraction of what it pays for rivals that have never filed a design application. SMR stock closed July 15, 2026 at $8.36 with a $3.06 billion market capitalisation, pennies above its $8.07 52-week low (<a href="https://stockanalysis.com/stocks/smr/" rel="noopener noreferrer nofollow">StockAnalysis, July 15, 2026</a>). Wall Street's targets now span $7 to $25 — a bear case 16% below spot and a bull case 199% above it — making this the widest risk-reward spread on the nuclear board.
Here is the take you will not find in the analyst notes: the market is currently paying roughly 10 times more, on an enterprise-value basis, for nuclear promises than for nuclear permission. When we published our <a href="https://financefeeds.com/oklo-stock-140-bull-case-14-bear-case/" rel="noopener noreferrer nofollow">Oklo bull/bear breakdown</a>, Oklo commanded a multi-billion-dollar valuation with its first reactor still working toward criticality and no NRC design certification in hand. NuScale — holding the certification Oklo lacks, a commercialisation partner funding deployment, and cash covering roughly 39% of its own market cap — trades at its lowest price since the AI-power trade began. One of these valuations is wrong. The bull case says it is NuScale's; the bear case says the market has correctly concluded that approval without revenue is just expensive paper.
Key Facts:
<blockquote>
 • SMR stock closed at $8.36 on July 15, 2026 — down 85% from its 52-week high of $57.42, with a $3.06 billion market cap — <a href="https://stockanalysis.com/stocks/smr/" rel="noopener noreferrer nofollow">StockAnalysis</a> • Street targets: $25 high, $7 low, roughly $15 average across 18 analysts (consensus: Hold) — StockAnalysis forecast data, July 2026 • Q1 2026 revenue was just $0.6 million against a $1.2 billion liquidity position — <a href="https://finance.biggo.com/news/US_SMR_2026-05-07" rel="noopener noreferrer nofollow">Q1 2026 earnings call, May 7, 2026</a> • Trailing-12-month revenue: $18.67 million, down 61.9%; trailing net loss: $385.8 million — StockAnalysis • TVA and ENTRA1 Energy agreed a framework for up to 6 GW of NuScale capacity — described as potentially the largest nuclear deployment programme in US history — <a href="https://www.nuscalepower.com/press-releases/2026/nuscale-power-reports-first-quarter-2026-results" rel="noopener noreferrer nofollow">NuScale</a> • Truist initiated coverage at Hold with a $10 target on July 14, 2026; BofA sits at $12 — StockAnalysis • NuScale remains the only SMR developer with an NRC-approved reactor design — company filings
</blockquote>
<h2 id="what-s-actually-happening-a-revenue-desert-between-two-catalysts">What's actually happening: a revenue desert between two catalysts</h2>
NuScale's business model explains both the collapse and the war chest. The company does not build reactors on its own balance sheet; it licenses its NRC-approved design and sells modules through ENTRA1 Energy, its exclusive global commercialisation partner. Until a power purchase agreement (PPA) is definitized and modules are ordered, revenue is little more than engineering services — which is how a company with a multi-gigawatt pipeline reported $0.6 million of first-quarter revenue while burning cash against a $385.8 million trailing loss.
The stock's 85% drawdown tracks that arithmetic. The 2025 melt-up priced NuScale as an AI-era power play alongside the data-centre build-out — the same trade that carried Applied Digital, whose own violent re-rating we mapped in our <a href="https://financefeeds.com/apld-stock-106-bull-case-40-bear-case/" rel="noopener noreferrer nofollow">APLD bull/bear analysis</a>. When quarterly numbers kept showing engineering-services revenue instead of module orders, the growth cohort rotated out, and a 96% year-over-year revenue decline in earlier quarters became the retail shorthand for a broken story.
What the shorthand misses is the liquidity: $1.2 billion, per the Q1 2026 call — enough to fund operations for years at the current burn rate without dilution. Management's framing of the pipeline has not wavered. "For NuScale, 2025 was a breakthrough year, in which we further solidified our position as the SMR industry's first mover," said John Hopkins, Chief Executive Officer at NuScale Power, citing ENTRA1's agreement with TVA "to deploy up to 6 gigawatts of NuScale small modular reactor capacity across TVA's seven-state service region." (<a href="https://www.nuscalepower.com/press-releases/2026/nuscale-power-reports-first-quarter-2026-results" rel="noopener noreferrer nofollow">NuScale Power</a>)
<div>Quick Take: NuScale is a licensing business in its pre-order phase: near-zero revenue, heavy losses, $1.2bn of cash, and one binary catalyst — converting the TVA framework into a definitized PPA.
</div>
<h2 id="industry-response-the-street-initiates-at-prove-it">Industry response: the Street initiates at "prove it"</h2>
The sell side's July moves frame the debate precisely. Truist initiated the entire small-modular-reactor complex — NuScale, Oklo and Nano Nuclear — at Hold on July 14, 2026, assigning NuScale a $10 target, with analyst Christopher Souther arguing the sector's "first-of-a-kind projects" are moving toward execution but have not arrived. "We view the company as a potential long-term beneficiary of accelerating power demand and increasing interest in advanced nuclear technologies. However, with commercialization still in its early stages, we believe greater visibility into first-of-a-kind (FOAK) plant economics and execution is needed before the risk-reward becomes more compelling," Souther wrote in the initiation note. (<a href="https://www.tipranks.com/news/the-fly/oklo-initiated-with-a-hold-at-truist-thefly-news" rel="noopener noreferrer nofollow">TipRanks/The Fly</a>)
BofA's $12 target sits in the same "show me" camp, and the 18-analyst consensus of Hold with a ~$15 average target implies 79% upside from spot — an unusual combination that says the Street believes the assets are worth roughly double the price but will not underwrite the timeline. On the counterparty side, ENTRA1 told NuScale that PPA discussions with TVA are "advancing well," and Hopkins told investors on the May 7 call, "We're hopeful that TVA can come across the line at some point later this year." Supplier activity continues beneath the headline numbers — Paragon was awarded design work in June — and TVA itself has stayed publicly quiet since the framework announcement, which cuts both ways: no reaffirmation, but no walk-back either.
The competitive context sharpens the initiation's meaning. Truist launched the whole SMR complex at Hold on the same day — Oklo at a $55 target, Nano Nuclear alongside — which means the Street's first synchronised look at the sector concluded that none of the three has yet earned a Buy, but priced NuScale's discount to its peers as roughly proportional to its drawdown rather than its assets. That is the gap the bull case attacks: identical sector risk, identical demand tailwind, but only one company in the cohort already holds the regulatory asset the others are still years from filing for.
<h2 id="market-impact-pricing-the-25-bull-against-the-7-bear">Market impact: pricing the $25 bull against the $7 bear</h2>
The bull-bear split is unusually clean because nearly all of NuScale's value sits in two line items: the cash and the TVA pipeline.
<table>
 <thead>
 <tr>
 <th></th>
 <th>Bull case — $25</th>
 <th>Bear case — $7</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>TVA / ENTRA1 PPA</td>
 <td>Definitized by year-end; 6 GW at ~77 MWe per module implies a multi-decade order book</td>
 <td>Slips into 2027 or shrinks; framework stays non-binding</td>
 </tr>
 <tr>
 <td>Cash ($1.2bn)</td>
 <td>Funds through first module orders, no dilution</td>
 <td>Burn accelerates with FOAK costs; equity raise below $10</td>
 </tr>
 <tr>
 <td>NRC approval</td>
 <td>Moat: years of licensing lead over every rival</td>
 <td>Wasting asset if rivals' applications advance while orders stall</td>
 </tr>
 <tr>
 <td>Revenue path</td>
 <td>Module orders convert pipeline to backlog in 2027</td>
 <td>$0.6M quarterly services revenue is the business, indefinitely</td>
 </tr>
 <tr>
 <td>Street anchor</td>
 <td>High target $25 (199% upside)</td>
 <td>Low target $7 (-16%); Truist $10, BofA $12 nearer spot</td>
 </tr>
 </tbody>
</table>
Sources: StockAnalysis (targets, financials, July 15, 2026); NuScale Q1 2026 earnings call (liquidity, TVA status, May 7, 2026).
The retail tape tells the same story from the other direction. Community discussion of NuScale over the past month clusters in small-cap value forums — r/smallstreetbets and critical-minerals communities rather than the momentum boards that carried the stock up — and the framing has shifted from "AI power play" to "cash-box with a catalyst," the classic signature of a name that has passed from growth hands to special-situation hands. Volume in the ticker's search demand has not decayed with the price: "smr stock" still draws roughly 297,000 US searches a month (Ahrefs, July 2026), fourth-highest among uncovered nuclear and AI-infrastructure tickers we track, which is why drawdown names in this sector keep producing outsized click-through — the audience is watching the wreckage for an entry.
The synthesis the single-source coverage misses: at $8.36, cash alone is worth about $3.28 per share, so the market prices everything else — certification, pipeline, first-mover position — near $5 a share, or roughly $1.9 billion. That is the same market that, across the nuclear and AI-power complex, still awards double-digit billions to pre-approval stories. Either the sector's optimism is misallocated, or NuScale is the cheapest claim on the same megatrend — the identical setup, in mirror image, to the one we flagged when <a href="https://financefeeds.com/coreweave-stock-303-bull-case-36-bear-case/" rel="noopener noreferrer nofollow">CoreWeave's bull case</a> hinged on converting contracted capacity into recognised revenue.
<div>Quick Take: $3.28/share of the $8.36 price is cash. The market is paying ~$1.9bn EV for the only NRC-approved SMR design and a 6 GW framework — while paying far more for rivals with neither.
</div>
<h2 id="the-regulatory-tension-approval-as-moat-timeline-as-tax">The regulatory tension: approval as moat, timeline as tax</h2>
Nuclear is the rare sector where the regulator is simultaneously the bull case and the bear case. NuScale's moat is entirely regulatory: it remains the only company whose SMR design has cleared NRC design approval, a process that consumed years and hundreds of millions of dollars — a barrier no competitor can shortcut. Every rival announcement, however well-funded, sits on the wrong side of that queue.
But the same apparatus sets the pace of monetisation. A definitized TVA PPA still leads to combined licence applications, site work and FOAK construction — each stage a regulatory gate with its own clock. That is why Souther's note anchors on "FOAK plant economics and execution" rather than demand: policy support for nuclear has rarely been stronger, with data-centre power demand pulling utilities toward firm, carbon-free capacity, yet not one US SMR has completed the journey from certification to commercial operation. The push-pull is structural: Washington wants the reactors built and simultaneously operates the machinery that makes building them slow. For institutional allocators, that converts NuScale into a duration bet — the asset is real, the discount rate on its timeline is the whole argument.
The jurisdictional footnote matters too: because TVA is a federally owned utility, a definitized PPA would put the first multi-module NuScale deployment inside a counterparty that cannot go bankrupt and answers to the same government that runs the licensing queue — the closest thing to political de-risking available in US nuclear. That is the detail the $7 bear target implicitly discounts to zero.
<h2 id="what-happens-next-three-predictions">What happens next: three predictions</h2>
1. The TVA definitization is the stock through year-end. Management has guided to "later this year"; Truist has effectively said it will re-rate on execution. If a binding PPA lands, the $10–$12 cluster of targets becomes stale overnight and the $25 high target becomes the new anchor — the causal chain runs from PPA to module orders to the first real backlog in company history. If it slips, the $7 bear target is the only Street number that matters, because the story rolls to 2027 with another year of burn.
2. The August earnings print will not matter — unless liquidity does. Revenue near zero is already priced; the line to watch is the cash. Anything materially below $1.1 billion reopens the dilution question at exactly the wrong share price.
3. Consolidation pressure builds if the price stays here. A certified design at a ~$1.9 billion enterprise value is cheaper than a from-scratch licensing programme for any hyperscaler, utility or industrial buyer serious about SMRs — the same strategic-asset logic that has repeatedly put discounted infrastructure in play across the AI-power complex. NuScale below $10 for two more quarters invites an approach, and the board's recent refresh adds two directors' worth of deal experience.
<h2 id="faq">FAQ</h2>
What is the bull case for SMR stock? $25 — the Street-high target. It requires the TVA/ENTRA1 framework for up to 6 GW to become a definitized PPA this year, converting NuScale's NRC-approved design and $1.2 billion war chest into the sector's first real order book. That is 199% above the July 15, 2026 close of $8.36.
What is the bear case for SMR stock? $7 — the Street-low target, about 16% below spot. It assumes the TVA deal slips or shrinks, quarterly revenue stays near $0.6 million, and cash burn forces dilution before the first module order arrives.
Why has NuScale stock dropped 85%? The 2025 AI-power melt-up priced module orders that have not yet arrived. Trailing revenue fell 61.9% to $18.67 million against a $385.8 million net loss, and growth capital rotated out as quarterly prints kept showing engineering-services revenue instead of reactor sales.
Is NuScale the only NRC-approved SMR company? Yes — NuScale remains the only small-modular-reactor developer with an NRC-approved design, a multi-year regulatory lead its competitors, including Oklo and Nano Nuclear, have not yet matched.
What is the analyst price target for NuScale (SMR)? Roughly $15 on average across 18 analysts (consensus Hold), spanning $7 to $25. The freshest marks are Truist's $10 (initiated July 14, 2026) and BofA's $12.
How much cash does NuScale have? Roughly $1.2 billion in liquidity as of the Q1 2026 earnings call on May 7, 2026 — about 39% of the entire $3.06 billion market cap, equivalent to roughly $3.28 per share at the July 15 close.
What should investors watch next for SMR stock? Three dates: the Q2 2026 earnings report in early August (cash position above all), any TVA/ENTRA1 PPA definitization announcement into year-end, and NRC-related filings that would signal the first combined licence application under the TVA programme.
This article is informational analysis only and is not investment advice. Equities are volatile and can lose substantial value. Do your own research.

NuScale SMR Stock: $25 Bull Case, $7 Bear Case

Table of Contents

FinanceFeeds

Other articles published on Jul 16, 2026

Join our free newsletter for daily crypto updates!